Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,330,127
+$49,471,286 QoQ
Shares Held
90,318
+41.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#368
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. LLY ranks #1 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,330,127 | 90,318 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $58,858,841 | 63,993 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $96,055,982 | 89,381 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $70,244,832 | 92,064 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $66,189,892 | 84,910 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $60,932,336 | 73,776 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $69,333,320 | 89,810 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $71,303,109 | 80,483 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $79,034,241 | 87,294 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $64,545,007 | 82,967 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $47,720,162 | 81,864 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $45,031,904 | 83,838 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $36,116,149 | 77,010 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,521,218 | 71,403 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $25,122,964 | 68,672 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,896,289 | 42,976 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,462,552 | 19,932 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,419,560 | 25,909 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,351,787 | 30,236 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,588,159 | 28,514 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,474,721 | 19,496 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,380,881 | 18,097 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,018,183 | 17,876 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,635,348 | 17,804 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,580,273 | 21,807 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,303,968 | 9,400 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||